Cardiovascular gains and sustained weight loss justify use for most, yet affordability looms: high costs strain patients, taxpayers, and governments, especially if surgery-eligible patients stall bariatric options
Recently, in addition to the central maintenance of food intake, GLP-1R signaling has begun to be considered in the context of the regulation of the stress response, as it is indicated that it can activate both the hypothalamicpituitaryadrenal (HPA) axis as well as the sympathetic nervous system [15, 16]
Worth EVERY penny
Brand-name Rybelsus uses a proprietary absorption enhancer (SNAC) to improve bioavailability
Helps fight hangover symptoms
However, no head-to-head comparisons of GLP-1RAs and other non-insulin glucose-lowering medications exist for patients with NAFLD and type 2 diabetes